
    
      To evaluate the influence of concomitant food ingestion on the pharmacokinetics of HRZE in
      newly diagnosed TB patients To evaluate the influence of early disease on the PK parameters
      of HRZE in TB patients To compare the pharmacokinetics of HRZE in the early stage of disease
      with the pharmacokinetics of HRZE in more stable condition in newly diagnosed TB patients To
      evaluate adverse events of HRZE in TB patients
    
  